We’re excited to introduce a new option in Curative’s plan lineup: the EPO Value Plan — designed for cost-conscious groups looking to offer a lower monthly premium while still giving members access to $0 care.
A few weeks ago, a report sent shockwaves through the individual health insurance market: the Wakely National Risk Adjustment Reporting (WNRAR) study. Since its release, Centene has withdrawn its earnings guidance and watched its stock fall nearly 40 percent. Oscar, Molina, and Elevance have all posted concerning Q2 earnings. Bloomberg has described the situation as a possible health insurer meltdown.
The Medicaid-insurer money machine is breaking down fast. In just one year look at these numbers: Centene- -57% UnitedHealth- -56% Molina- -48% Humana- crashing toward $300/share
Dear George, I have a meeting with my CFO this morning. He expects an update on our September 2025 renewal in preparation for next week’s meeting with our BUCA Broker representing __________________ (Pick One: Marsh, Willis, Gallagher, Higgenbotham, other)